{"id":"W2196580706","doi":"10.1200/jco.2010.28.18_suppl.lba7005","title":"A phase III randomized, double-blind, placebo-controlled trial of the epidermal growth factor receptor inhibitor gefitinb in completely resected stage IB-IIIA non-small cell lung cancer (NSCLC): NCIC CTG BR.19.","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Gefitinib; Internal medicine; Placebo; Lung cancer; Rash; Gastroenterology; Hazard ratio; Epidermal growth factor receptor; Surgery; Cancer; Oncology; Pathology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002538952,0.002883522,0.004841978,0.000607437,0.0009137392,0.00159126,0.001435707,0.002909047,0.01082846],"category_scores_gemma":[0.003216839,0.001139253,0.00230476,0.000564392,0.001623486,0.00148069,0.0005920341,0.003921432,0.002054096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001184295,"about_ca_system_score_gemma":0.001735272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001755447,"about_ca_topic_score_gemma":0.004498177,"domain_scores_codex":[0.9990066,0.0005067889,0.000071813,0.0002127199,0.00007335254,0.0001287611],"domain_scores_gemma":[0.9988426,0.0002967963,0.0003138179,0.0001093494,0.0001059264,0.0003313361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9898732,0.003063632,0.0001872729,0.0006505327,0.0008358811,0.0000200123,0.00002758892,0.0000974321,0.0008629986,0.00005578778,0.0007689105,0.003556813],"study_design_scores_gemma":[0.9898987,0.0091081,0.0002555492,0.00001669404,0.0002866451,0.000008681802,0.000006089705,0.00008986539,0.00006964733,0.00005300809,0.0002024213,0.00000455946],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.940868,0.01456984,0.00201716,0.002851296,0.003556334,0.02397955,0.005737949,0.0006119235,0.005807898],"genre_scores_gemma":[0.9534075,0.00516448,0.00329799,0.003508266,0.00103669,0.02335157,0.002915533,0.00007238835,0.007245673],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01082846,"threshold_uncertainty_score":0.03622484,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08185732026370005,"score_gpt":0.4656413726622132,"score_spread":0.3837840523985132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}